Completed NA INTERVENTIONAL 1-arm NCT02112812

Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease

A Study on Clinical Response Following Eradication Therapy of Helicobacter Pylori Infection in Parkinson's Disease

Sponsor: National University of Malaysia

Conditions Motor Outcomes Quality of Life Outcomes Response to Levodopa

Interventions Eradication of Helcobacter Pylori Eradication therapy for H.pylori infection Eradication therapy for Helicobacter pylori

Updated 4 times since 2017 Last updated: Apr 10, 2014 Started: Dec 31, 2012 Primary completion: Mar 31, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02112812, this NA trial focuses on Motor Outcomes and Quality of Life Outcomes and remains completed. Sponsored by National University of Malaysia, it has been updated 4 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National University of Malaysia

Data source: National University of Malaysia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cheras, Malaysia